Neil Glasser joined MJH Life Sciences^® as chief financial officer in 2011. He is responsible for the financial management of the company, all M&A activity, and legal affairs. During his tenure, he has been integral to scaling the company’s financial and legal functions to meet its growth. He has also managed the human resources, circulation, and IT functions at various times. Neil led the acquisitions of Physicians’ Education Resource^®, LLC (PER^®); CURE Media Group; the Chemotherapy Foundation Symposium; the Atlantic Coast Veterinary Conference^®; UBM Life Sciences Group; Element – The Data Agency, the Pharmacy Benefit Management Institute, and Pharmaceutical Commerce^®.

Before joining MJH, Neil was vice president of finance for Sterling Publishing Co., a wholly owned subsidiary of Barnes & Noble (B&N). At Sterling, he oversaw all finance operations for B&N’s publishing division, which represented over $200 million in retail sales. Previously, he was vice president of finance at UniTeller Financial Services, Inc., an innovations leader in the money transfer business. He guided the company through a successful sale to Grupo Financiero Banorte, a Forbes Global 2000 company, with more than $30 billion in assets under management. Neil received a 2017 Innovation Award from CFO Studio for his work at MJH. In 2018, Neil was a finalist for the New Jersey Tech Council CFO of the Year.

Favorite sports team: Pittsburgh Steelers
Favorite movie: “Max Dugan Returns”
Favorite place to unwind: My back deck
Favorite food: Anything chocolate